KB

Komal Bipinkumar Vachhani

Active Director Director DIN 08195389
DIN 08195389 First appointment Aug 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Komal Bipinkumar Vachhani

Data last updated:

Komal Bipinkumar Vachhani is a Director at Saju Life Science Private Limited (since 2018). The company operates in Healthcare.

DIN 08195389
Primary Designation Director
Industry Healthcare
First Appointment 07 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saju Life Science Private Limited U85190GJ2018PTC103560
Director07 Aug 20182018Active

Board colleagues of Komal Bipinkumar Vachhani

NameDINCompanyDesignation
Bipinbhai Savjibhai Vachhani07755768Saju Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Saju Life Science Private Limited
Premium access

Shareholding and investment profile for Komal Bipinkumar Vachhani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Komal Bipinkumar Vachhani

Komal Bipinkumar Vachhani currently holds 1 directorship: Saju Life Science Private Limited (Director, since 07 Aug 2018).

Komal Bipinkumar Vachhani was first appointed on 07 Aug 2018 as Director at Saju Life Science Private Limited.

The current boards of Komal Bipinkumar Vachhani's companies include Bipinbhai Savjibhai Vachhani (Saju Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available